BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37548271)

  • 21. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
    Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
    J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
    Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M
    Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
    Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
    Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1.
    Thomas C; Knerlich-Lukoschus F; Reinhard H; Johann PD; Sturm D; Sahm F; Bens S; Vogt J; Nemes K; Oyen F; Kordes U; Siebert R; Schneppenheim R; Messing-Jünger M; Pietsch T; von Deimling A; Paulus W; Pfister SM; Kool M; Frühwald MC; Hasselblatt M
    Acta Neuropathol; 2019 May; 137(5):847-850. PubMed ID: 30945057
    [No Abstract]   [Full Text] [Related]  

  • 25. Malignant progression of a peripheral nerve sheath tumor in the setting of rhabdoid tumor predisposition syndrome.
    Upadhyaya SA; McGee RB; Wilky BA; Broniscer A
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27030. PubMed ID: 29512865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
    Fukushima H; Yamasaki K; Sakaida M; Tsujio N; Okuno T; Ishii N; Okada K; Fujisaki H; Matsusaka Y; Sakamoto H; Yoneda A; Hara J; Inoue T
    Pathol Int; 2021 Feb; 71(2):155-160. PubMed ID: 33378586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description.
    Barresi V; Lionti S; Raso A; Esposito F; Cannavò S; Angileri FF
    Neuropathology; 2018 Jun; 38(3):260-267. PubMed ID: 29110337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison.
    Pacheco MC; Dolan M; Bendel A
    Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second rhabdoid tumor 8 years after treatment of atypical teratoid/rhabdoid tumor in a child with germline SMARCB1 mutation.
    Bhatt MD; Al-Karmi S; Druker H; Gupta A; Lu M; Malkin D; Somers G; Huang A; Bouffet E
    Pediatr Blood Cancer; 2019 Mar; 66(3):e27546. PubMed ID: 30393974
    [No Abstract]   [Full Text] [Related]  

  • 30. Spontaneous Regression of Atypical Teratoid Rhabdoid Tumor Without Therapy in a Patient With Uncommon Regional Inactivation of SMARCB1 ( hSNF5/INI1).
    Peterson JEG; Bavle A; Mehta VP; Rauch RA; Whitehead WE; Mohila CA; Su JM; Adesina AM
    Pediatr Dev Pathol; 2019; 22(2):161-165. PubMed ID: 30470167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical teratoid/rhabdoid tumour-TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition.
    Lee JC; Tran QT; McGee RB; Perrino MR; Upadhyaya SA; Hanzlik EM; Pytel N; Carroll AJ; Orisme W; Eldomery M; Wang L; Blackburn PR; Furtado LV; Viaene AN; Luo M; Kalish JM; Pinto SN; Bag AK; Orr BA
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12971. PubMed ID: 38488196
    [No Abstract]   [Full Text] [Related]  

  • 33. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
    Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
    Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
    Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
    J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
    Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
    J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system.
    Bruggers CS; Bleyl SB; Pysher T; Barnette P; Afify Z; Walker M; Biegel JA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1026-31. PubMed ID: 20848638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.